Fluorescent Protein Assay Testing in Medical Devices

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Fluorescent Protein Assay Testing in Medical Devices

Sector: Diagnostics
YouTube video thumbnail

Understanding the Fluorescent Protein Assay

In this Bio Break episode, Nick Allan and Nigel Syrotuck explain how a fluorescent protein assay helps engineers measure contamination and cleaning performance in medical devices. At StarFish Medical, the team develops controlled soil mixtures that safely simulate bodily fluids. These “artificial soil loads” allow precise testing of how effectively a device can resist or release contaminants.

The Science Behind Soil Load Visualization

To make invisible residues measurable, fluorescent dyes are introduced into the protein-based soil. Nick describes how common assays such as the Bradford Comassi and BCA assay use chemical reactions to bind with protein molecules. When exposed to certain light wavelengths, these compounds absorb and emit light differently, creating measurable fluorescence. This allows researchers to see exactly how much protein remains after cleaning.

Quantifying Cleaning Performance in MedTech

By using fluorescence to detect trace contamination, engineers can go beyond visual inspection. As Nigel and Nick discuss, results compared against a standard curve reveal how well a device resists soil accumulation or supports effective cleaning. These insights guide medical device developers toward safer, more reliable designs that meet regulatory expectations.

Nick and Nigel demonstrating how aminoglycoside antibiotics work using Lego bricks in a Bio Break episode

Nick Allan and Nigel Syrotuck explain exactly how aminoglycoside antibiotics work and why they’re so effective at killing bacteria.

Engineer reviewing a colorful mind map diagram across dual monitors and laptop while collaborating with a remote team on a video call during an online whiteboard risk analysis session

Graphical mind maps created in online whiteboards offer a low-barrier, highly collaborative approach to early risk analysis in medical device development.

Product designer sketching early-phase concept wireframes on glass whiteboard during ideation session

Early phase concept development is a weird part of a project lifecycle. It is often the most exciting phase, because the team is exploring possibilities, generating new ideas, and turning a fuzzy opportunity into something real.

Engineer in cleanroom assembling precision medical device prototype with optical components

Clinical prototypes must not only function as intended, but also be manufactured, documented, and supported in a way that satisfies regulatory expectations and clinical realities.